Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C19H24O2 |
| Molecular Weight | 284.3927 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@]12C
InChI
InChIKey=CCCIJQPRIXGQOE-XWSJACJDSA-N
InChI=1S/C19H24O2/c1-18-9-7-15-14-6-4-13(20)11-12(14)3-5-16(15)17(18)8-10-19(18,2)21/h7,9,11,16-17,21H,3-6,8,10H2,1-2H3/t16-,17+,18+,19+/m1/s1
| Molecular Formula | C19H24O2 |
| Molecular Weight | 284.3927 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Metribolone, also known as methyltrienolone, an anabolic agent, binds to the androgen receptor and was studied for the treatment of advanced breast cancer. However, because of the liver toxicity, further development of this drug was discontinued. Now, this compound is used for research purpose as synthetic androgen.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| The Flame-Retardant Tris(1,3-dichloro-2-propyl) Phosphate Represses Androgen Signaling in Human Prostate Cancer Cell Lines. | 2016-05 |
|
| Low dose evaluation of the antiandrogen flutamide following a Mode of Action approach. | 2015-12-15 |
|
| LncRNA HOTAIR Enhances the Androgen-Receptor-Mediated Transcriptional Program and Drives Castration-Resistant Prostate Cancer. | 2015-10-06 |
|
| p,p'-Dichlorodiphenyltrichloroethane (p,p'-DDT) and p,p'-dichlorodiphenyldichloroethylene (p,p'-DDE) repress prostate specific antigen levels in human prostate cancer cell lines. | 2015-03-25 |
|
| Copper signaling axis as a target for prostate cancer therapeutics. | 2014-10-15 |
|
| Currently used pesticides and their mixtures affect the function of sex hormone receptors and aromatase enzyme activity. | 2013-10-15 |
|
| Simultaneous determination of the UV-filters benzyl salicylate, phenyl salicylate, octyl salicylate, homosalate, 3-(4-methylbenzylidene) camphor and 3-benzylidene camphor in human placental tissue by LC-MS/MS. Assessment of their in vitro endocrine activity. | 2013-10-01 |
|
| Metallothionein 3: an androgen-upregulated gene enhances cell invasion and tumorigenesis of prostate carcinoma cells. | 2013-10 |
|
| Bisphenol A affects androgen receptor function via multiple mechanisms. | 2013-05-25 |
|
| Ligand-independent androgen receptor antagonism caused by the newly developed pesticide pyrifluquinazon (PFQ). | 2013-01 |
|
| Androgen receptor promotes ligand-independent prostate cancer progression through c-Myc upregulation. | 2013 |
|
| Anti-androgen effects of cypermethrin on the amino- and carboxyl-terminal interaction of the androgen receptor. | 2012-02-26 |
|
| Inactivation of ATM/ATR DNA damage checkpoint promotes androgen induced chromosomal instability in prostate epithelial cells. | 2012 |
|
| The DEK oncogene is a target of steroid hormone receptor signaling in breast cancer. | 2012 |
|
| Biological properties of androgen receptor pure antagonist for treatment of castration-resistant prostate cancer: optimization from lead compound to CH5137291. | 2011-09 |
|
| Acyl derivatives of p-aminosulfonamides and dapsone as new inhibitors of the arginine methyltransferase hPRMT1. | 2011-06-15 |
|
| Testosterone augments polyphenol-induced DNA damage response in prostate cancer cell line, LNCaP. | 2011-02 |
|
| Androgen-regulated expression of arginase 1, arginase 2 and interleukin-8 in human prostate cancer. | 2010-08-11 |
|
| Identification of the GATA factor TRPS1 as a repressor of the osteocalcin promoter. | 2009-11-13 |
|
| Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells. | 2009-09-10 |
|
| Cumulative and antagonistic effects of a mixture of the antiandrogens vinclozolin and iprodione in the pubertal male rat. | 2009-09 |
|
| Transcriptional repression and inhibition of nuclear translocation of androgen receptor by diallyl trisulfide in human prostate cancer cells. | 2009-08-01 |
|
| Genome-wide impact of androgen receptor trapped clone-27 loss on androgen-regulated transcription in prostate cancer cells. | 2009-04-01 |
|
| Inhibition of androgen receptor transcriptional activity as a novel mechanism of action of arsenic. | 2009-03 |
|
| A novel dietary flavonoid fisetin inhibits androgen receptor signaling and tumor growth in athymic nude mice. | 2008-10-15 |
|
| Effects of manganese superoxide dismutase silencing on androgen receptor function and gene regulation: implications for castration-resistant prostate cancer. | 2008-10-01 |
|
| Differential effects of resveratrol on androgen-responsive LNCaP human prostate cancer cells in vitro and in vivo. | 2008-10 |
|
| Curcumin blocks the activation of androgen and interlukin-6 on prostate-specific antigen expression in human prostatic carcinoma cells. | 2008-08-05 |
|
| Screening of 397 chemicals and development of a quantitative structure--activity relationship model for androgen receptor antagonism. | 2008-04 |
|
| Parathyroid hormone-related protein varies with sex and androgen status in nonsmall cell lung cancer. | 2007-09-15 |
|
| Androgen-dependent regulation of medium and long chain fatty acids uptake in prostate cancer. | 2007-09-01 |
|
| The role of androgen in determining differentiation and regulation of androgen receptor expression in the human prostatic epithelium transient amplifying population. | 2007-09 |
|
| Squalene synthase, a determinant of Raft-associated cholesterol and modulator of cancer cell proliferation. | 2007-06-29 |
|
| Labeling and identification of LNCaP cell surface proteins: a pilot study. | 2007-06-15 |
|
| Androgen regulation of aldehyde dehydrogenase 1A3 (ALDH1A3) in the androgen-responsive human prostate cancer cell line LNCaP. | 2007-06 |
|
| Testosterone activates mitogen-activated protein kinase via Src kinase and the epidermal growth factor receptor in sertoli cells. | 2007-05 |
|
| Beta-2-microglobulin is an androgen-regulated secreted protein elevated in serum of patients with advanced prostate cancer. | 2007-04-01 |
|
| Proteomics analysis of the interactome of N-myc downstream regulated gene 1 and its interactions with the androgen response program in prostate cancer cells. | 2007-04 |
|
| Rapid, non-destructive, cell-based screening assays for agents that modulate growth, death, and androgen receptor activation in prostate cancer cells. | 2007-03-01 |
|
| Curcumin downregulates homeobox gene NKX3.1 in prostate cancer cell LNCaP. | 2007-03 |
|
| Ligand-specific dynamics of the androgen receptor at its response element in living cells. | 2007-03 |
|
| 17beta-Estradiol differentially regulates androgen-responsive genes through estrogen receptor-beta- and extracellular-signal regulated kinase-dependent pathways in LNCaP human prostate cancer cells. | 2007-02 |
|
| The synthetic androgen methyltrienolone (r1881) acts as a potent antagonist of the mineralocorticoid receptor. | 2007-02 |
|
| Differential regulation of clusterin and its isoforms by androgens in prostate cells. | 2007-01-26 |
|
| Androgen induces adaptation to oxidative stress in prostate cancer: implications for treatment with radiation therapy. | 2007-01 |
|
| Evaluation of an in vitro model of androgen ablation and identification of the androgen responsive proteome in LNCaP cells. | 2007-01 |
|
| Testosterone and progesterone rapidly attenuate plasma membrane Gbetagamma-mediated signaling in Xenopus laevis oocytes by signaling through classical steroid receptors. | 2007-01 |
|
| p53 overexpression represses androgen-mediated induction of NKX3.1 in a prostate cancer cell line. | 2006-12-31 |
|
| Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators. | 2006-10 |
|
| Topographic recognition of cyclic hydrocarbons and related compounds by receptors for androgens, estrogens, and glucocorticoids. | 1987 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 08:31:46 GMT 2025
by
admin
on
Wed Apr 02 08:31:46 GMT 2025
|
| Record UNII |
2C323EGI97
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
DEA NO. |
4000
Created by
admin on Wed Apr 02 08:31:46 GMT 2025 , Edited by admin on Wed Apr 02 08:31:46 GMT 2025
|
||
|
WIKIPEDIA |
Designer-drugs-Metribolone
Created by
admin on Wed Apr 02 08:31:46 GMT 2025 , Edited by admin on Wed Apr 02 08:31:46 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
965-93-5
Created by
admin on Wed Apr 02 08:31:46 GMT 2025 , Edited by admin on Wed Apr 02 08:31:46 GMT 2025
|
PRIMARY | |||
|
2180
Created by
admin on Wed Apr 02 08:31:46 GMT 2025 , Edited by admin on Wed Apr 02 08:31:46 GMT 2025
|
PRIMARY | |||
|
METRIBOLONE
Created by
admin on Wed Apr 02 08:31:46 GMT 2025 , Edited by admin on Wed Apr 02 08:31:46 GMT 2025
|
PRIMARY | |||
|
C166564
Created by
admin on Wed Apr 02 08:31:46 GMT 2025 , Edited by admin on Wed Apr 02 08:31:46 GMT 2025
|
PRIMARY | |||
|
261000
Created by
admin on Wed Apr 02 08:31:46 GMT 2025 , Edited by admin on Wed Apr 02 08:31:46 GMT 2025
|
PRIMARY | |||
|
2C323EGI97
Created by
admin on Wed Apr 02 08:31:46 GMT 2025 , Edited by admin on Wed Apr 02 08:31:46 GMT 2025
|
PRIMARY | |||
|
379896
Created by
admin on Wed Apr 02 08:31:46 GMT 2025 , Edited by admin on Wed Apr 02 08:31:46 GMT 2025
|
PRIMARY | |||
|
DB02998
Created by
admin on Wed Apr 02 08:31:46 GMT 2025 , Edited by admin on Wed Apr 02 08:31:46 GMT 2025
|
PRIMARY | |||
|
SUB08918MIG
Created by
admin on Wed Apr 02 08:31:46 GMT 2025 , Edited by admin on Wed Apr 02 08:31:46 GMT 2025
|
PRIMARY | |||
|
DTXSID8034162
Created by
admin on Wed Apr 02 08:31:46 GMT 2025 , Edited by admin on Wed Apr 02 08:31:46 GMT 2025
|
PRIMARY | |||
|
92858
Created by
admin on Wed Apr 02 08:31:46 GMT 2025 , Edited by admin on Wed Apr 02 08:31:46 GMT 2025
|
PRIMARY | |||
|
m7473
Created by
admin on Wed Apr 02 08:31:46 GMT 2025 , Edited by admin on Wed Apr 02 08:31:46 GMT 2025
|
PRIMARY | Merck Index | ||
|
CHEMBL166444
Created by
admin on Wed Apr 02 08:31:46 GMT 2025 , Edited by admin on Wed Apr 02 08:31:46 GMT 2025
|
PRIMARY | |||
|
100000080945
Created by
admin on Wed Apr 02 08:31:46 GMT 2025 , Edited by admin on Wed Apr 02 08:31:46 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
LABELED -> NON-LABELED |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |